|
DNAJC18 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.671580E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.583000E-01 |
| Normal-vs-Stage2 |
1.057640E-02 |
| Normal-vs-Stage3 |
3.170600E-04 |
| Normal-vs-Stage4 |
2.794600E-04 |
| Stage1-vs-Stage2 |
2.060400E-02 |
| Stage1-vs-Stage3 |
7.67500000000698E-05 |
| Stage1-vs-Stage4 |
2.441600E-04 |
| Stage2-vs-Stage3 |
5.161600E-01 |
| Stage2-vs-Stage4 |
4.189000E-01 |
| Stage3-vs-Stage4 |
8.244000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.887600E-02 |
| Normal-vs-AfricanAmerican |
6.663700E-03 |
| Normal-vs-Asian |
3.937800E-01 |
| Caucasian-vs-AfricanAmerican |
1.470760E-01 |
| Caucasian-vs-Asian |
9.454800E-01 |
| AfricanAmerican-vs-Asian |
6.290200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.115930E-02 |
| Normal-vs-Female |
9.298100E-02 |
| Male-vs-Female |
4.160200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.918600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.469800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.801600E-03 |
| Normal-vs-Age(81-100Yrs) |
1.690250E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.542000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.894000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.247000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.047420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.596770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.364600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.660600E-01 |
| Normal-vs-Grade 2 |
9.459800E-01 |
| Normal-vs-Grade 3 |
1.316950E-03 |
| Normal-vs-Grade 4 |
1.4440000000171E-06 |
| Grade 1-vs-Grade 2 |
4.864400E-01 |
| Grade 1-vs-Grade 3 |
1.744020E-02 |
| Grade 1-vs-Grade 4 |
5.392100E-04 |
| Grade 2-vs-Grade 3 |
2.13779999999053E-05 |
| Grade 2-vs-Grade 4 |
5.020799997979E-08 |
| Grade 3-vs-Grade 4 |
3.173800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.104800E-01 |
| Normal-vs-ccB subtype |
6.389600E-04 |
| ccA subtype-vs-ccB subtype |
5.90359999996792E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.158310E-02 |
| Normal-vs-N1 |
3.084800E-03 |
| N0-vs-N1 |
1.331630E-01 |
|
|
